Gallery

Check out Best Practices’ Other Social Media Accounts!

We’ve just added some great new material on all of our social media accounts! Feel free to browse around a bit more for more information on Best Practices, LLC! LinkedIn Slideshare Pinterest Twitter Google+ YouTube Facebook

Gallery

Medical Affairs Consortium: Impact Measures, Globalization & Compliance

On November 6, 2014 Best Practices, LLC hosted the 1st roundtable of the 2014-2015 Medical Affairs’ Consortium. The roundtable brought together leaders from: Baxter, Crescendo, Eli Lilly, Genentech, Incyte Corporation, Jazz Pharmaceuticals, Pfizer, Santen Inc., Teva, and Upsher-Smith. Leaders from … Continue reading

Gallery

How To: Stop “No” From Being a 4-Letter Word

Author: Cameron Tew (Executive Director of Research) Not too long ago, a colleague jokingly compared me to a consigliere. (Think Marlon Brando in “The Godfather”). He said he didn’t know how I got any work done, as people wander in … Continue reading

Gallery

5 Things Pharma Professionals Need to Know About Big Data

This gallery contains 1 photos.

Author: Andrew Bryk (Research Analyst) Big Data has its roots in a set of statistical methods called econometrics A main feature of the finance, biology, and the social sciences is the apparent randomness of the behaviors being measured. Econometrics exists to … Continue reading

Gallery

Best Practices’ Hosting Medical Affairs Consortium Roundtable Thursday, Nov. 6

Best Practices designed the Medical Affairs Consortium to provide Medical Affairs leaders with a forum for sharing insights about the key challenges they face. The consortium has developed a mechanism for creating and sharing solutions through three virtual roundtable discussions … Continue reading

Gallery

Big Data in Pharma: What is Big Data?

This gallery contains 1 photos.

Author: Andrew Bryk (Research Analyst) We are past the peak of the Big Data hypecycle, not least of all because about half of the content on the topic put out by marketing gurus, branding experts, and other non-practitioners has moved on … Continue reading

Gallery

Pharma Companies Feeling the Heat From the Sunshine Act

Last week marked the release of the initial data from the Sunshine Act law of the Affordable Care Act, which had been dreaded by many health care professionals and pharmaceutical and medical device executives. So, for the past few years, … Continue reading

Gallery

Thou Shalt Build Credibility But Plan for the Worst

As pharma companies plan for the launch of new products, much of the discussion centers around how to position a new drug or device to the rest of the world. Still, much of that same planning can be internalized and … Continue reading